Tim Kümmerle
Impact in
- Hepatology top 10%
- Hepatitis C virus research
-
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 3
- HIV/AIDS Research and Interventions 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Co-authors
- Christoph Wyen (9 shared papers)Clara Lehmann (9 shared papers)Gerd Fätkenheuer (10 shared papers)Jürgen K. Rockstroh (6 shared papers)Christoph Boesecke (8 shared papers)Oliver A. Cornely (5 shared papers)Jörg Janne Vehreschild (5 shared papers)Martin Vogel (2 shared papers)
- Journals
- Infection (5 papers)HIV Medicine (2 papers)Antiviral Therapy (1 paper)Expert Opinion on Investigational Drugs (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Tim Kümmerle
20 papers receiving 221 citations
Peers
Comparison fields: 5 of 39
- Hepatology 84
- Virology 21
- Infectious Diseases 76
- Microbiology 19
- Epidemiology 94
Countries citing papers authored by Tim Kümmerle
This map shows the geographic impact of Tim Kümmerle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Kümmerle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Kümmerle more than expected).
Fields of papers citing papers by Tim Kümmerle
This network shows the impact of papers produced by Tim Kümmerle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Kümmerle. The network helps show where Tim Kümmerle may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Kümmerle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 52 | |
| 2 | 2013 | 31 | |
| 3 | 2010 | 29 | |
| 4 | 2014 | 18 | |
| 5 | 2018 | 16 | |
| 6 | 2007 | 14 | |
| 7 | 2012 | 14 | |
| 8 | 2016 | 10 | |
| 9 | 2014 | 8 | |
| 10 | 2017 | 8 | |
| 11 | 2018 | 6 | |
| 12 | 2009 | 6 | |
| 13 | 2020 | 4 | |
| 14 | [Value of p53, urokinase plasminogen activator, PAI-1 and Ki-67 in vulvar carcinoma]. | 1999 | 4 |
| 15 | 2021 | 3 | |
| 16 | 2011 | 3 | |
| 17 | 2016 | 3 | |
| 18 | 2015 | 2 | |
| 19 | 2022 | 1 | |
| 20 | 2012 | 1 |
About Tim Kümmerle
Tim Kümmerle is a scholar working on Infectious Diseases, Epidemiology, Physiology, Emergency Medicine and Hepatology, having authored 20 papers that have together received 233 indexed citations. Recurring topics across this work include HIV-related health complications and treatments (3 papers), HIV/AIDS drug development and treatment (3 papers), Syphilis Diagnosis and Treatment (3 papers), HIV/AIDS Research and Interventions (2 papers), Hepatitis C virus research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Vaccine Coverage and Hesitancy (1 paper) and Poxvirus research and outbreaks (1 paper). The work is most often cited by research in Hepatology (84 citations), Virology (21 citations), Infectious Diseases (76 citations), Microbiology (19 citations) and Epidemiology (94 citations). Tim Kümmerle has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Christoph Wyen, Clara Lehmann, Gerd Fätkenheuer, Jürgen K. Rockstroh, Christoph Boesecke, Oliver A. Cornely, Jörg Janne Vehreschild, Martin Vogel, Gaby Knecht and Norma Jung. Their work appears in journals such as Infection, HIV Medicine, Antiviral Therapy, Expert Opinion on Investigational Drugs and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.